Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis
2018/08/15 by Elizabeth A. McAninch, Elizabeth A McAninch, Kumar B. Rajan +5 · 27 citations
Medicine · #Thyroid Disorders and Treatments #Thyroid Cancer Diagnosis and Treatment #Parathyroid Disorders and Treatments
paper · pdf · doi:10.1210/jc.2018-01361
Abstract
CONTEXT: The standard of care for overt hypothyroidism is levothyroxine at doses that normalize serum TSH levels. Whether this approach universally restores thyroid hormone signaling is unknown. OBJECTIVE: To review studies of overt hypothyroidism in which participants were treated with levothyroxine to normalize serum TSH levels and measured other objective markers of thyroid hormone signaling. DESIGN: Databases were searched for studies that reported objective markers of thyroid hormone signaling (serum low-density lipoprotein (LDL), total cholesterol (TC), sex hormone-binding globulin (SHBG), creatine kinase and/or ferritin levels; cognition, energy expenditure, and/or renal function) in levothyroxine monotherapy for overt, primary hypothyroidism among nonpregnant adults with normal serum TSH levels. For studies with LDL, TC and SHBG outcomes, data were pooled using random effects meta-analysis. RESULTS: A total of 99 studies met inclusion criteria, including 65 that reported serum cholesterol data. Meta-analysis showed that levothyroxine-treated hypothyroid participants with normal serum TSH levels had 3.31 ± 1.64 mg/dL higher serum LDL levels (p=0.044) and 9.60 ± 3.55 mg/dL higher serum TC levels (p=0.007) compared to controls. In studies that did not concomitantly assess healthy controls, serum LDL levels were 138.3 ± 4.6 mg/dL (p<0.001) and serum TC levels were 209.6 ± 3.4 mg/dL (p<0.001). Meta-analysis of 2 studies showed no significant difference between SHBG levels of levothyroxine-treated participants and controls. CONCLUSIONS: In studies that utilized levothyroxine monotherapy at doses that normalized the serum TSH for overt, primary hypothyroidism, not all systemic biological markers of thyroid hormone signaling were normalized, including serum LDL and TC levels.
Cited by
- Mechanisms and clinical prospects of mesenchymal stem cells and their derivatives in treating hypothyroidism-induced injuries: A focus on cardiovascular, skeletal muscle, and nervous systems
- Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document
- Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis. [europepmc]
- Paradigms of Dynamic Control of Thyroid Hormone Signaling. [europepmc]
- Association between Thyroid-Stimulating Hormone Level after Total Thyroidectomy and Hypercholesterolemia in Female Patients with Differentiated Thyroid Cancer: A Retrospective Study. [europepmc]
- The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy. [europepmc]
- Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease. [europepmc]
- Sustained Release T3 Therapy: Animal Models and Translational Applications. [europepmc]
- Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options. [europepmc]
- Systemic Thyroid Hormone Status in Treated Graves' Disease. [europepmc]
- Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism. [europepmc]
- Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? [europepmc]
- Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study. [europepmc]
- Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. [europepmc]
- Effect of restoration of euthyroidism on visfatin concentrations and body composition in women. [europepmc]
- Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. [europepmc]
- Use of Statins Among Patients Taking Levothyroxine: an Observational Drug Utilization Study Across Sites. [europepmc]
- Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans. [europepmc]
- The relevance of T 3 in the management of hypothyroidism. [europepmc]
- Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It. [europepmc]
- Evaluating health outcomes in the treatment of hypothyroidism. [europepmc]
- T3 levels and thyroid hormone signaling. [europepmc]
- Age-related variation in thyroid function - a narrative review highlighting important implications for research and clinical practice. [europepmc]
- Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism? [europepmc]
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two. [europepmc]
- Emerging Therapies in Hypothyroidism. [europepmc]
- Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism. [europepmc]
Related